There is a strong correlation of PDZK1 with multiple signaling pathways including estrogen dependent IGF-1R and chemokine (C-X-C motif) receptor 4 (CXCR4) signaling which can be targeted therapeutically to treat breast cancer [24, 26, 124]. Here, PDZK1 is linked to breast carcinoma.